The Pharmacological Landscape of Sickle Cell Disease
Release Date: 8/19/2024
Expiration Date: 8/19/2025
Target Audience: This activity is designed for an audience of nurses, nurse practitioners, pharmacists, physician associates, physicians, and social workers.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- – Describe the pathophysiology of sickle cell disease.
- – Differentiate between available FDA approved treatments for sickle cell disease.
- – Utilize strategies and resources to support patients navigating treatment for sickle cell disease.
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and CCOPharma LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Credit being awarded: 1 ANCC contact hours
California Nurses
AKH Inc., Advancing Knowledge in Healthcare is a provider approved by the California Board of Registered Nursing, Provider Number CEP17011, for 1 contact hours.
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1 contact hour.
Physician Associate
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 8/19/2025. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and CCOPharma LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1 contact hour(s) (which includes 1 hour(s) of pharmacology).
Social Workers
As a Jointly Accredited Organization, AKH Inc., Advancing Knowledge in Healthcare is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AKH Inc. Advancing Knowledge in Healthcare maintains responsibility for this course. Social workers completing this course receive 1 continuing education credit.
Fee: $15.00
To access this activity, visit The Pharmacological Landscape of Sickle Cell Disease
Continuing Education Courses